Abstract:Eight previously undescribed lanostane triterpenoids, ganodeweberiols A ∼ H (1–8), together with eighteen known compounds (9–26), were isolated from the fruiting bodies of Ganoderma weberianum. The structures and absolute configurations of the new compounds were determined by extensive spectroscopic analysis, as well as NMR chemical shifts and electronic circular dichroism (ECD) calculations. Compounds 2, 7, 12, and 14 showed significant α-glucosidase inhibitory activity with IC50 values ranging from 35.3 μM ∼ 223.4 μM compared to the positive control acarbose (IC50, 304.6 μM). Kinetic study indicated that the most potent compound 12 was a mixed type inhibitor for α-glucosidase. Molecular docking simulation revealed the interactions of 12 with α-glucosidase. Additionally, Compounds 3 and 6 inhibited glucagon-induced hepatic glucose production in HepG2 cells with EC50 values of 42.0 and 85.9 μM, respectively. Further study revealed that compounds 3 and 6 inhibited hepatic glucose production by suppression glucagon-induced cAMP accumulation. Moreover, compounds 3 and 26 were active against HeLa cell line with IC50 values of 17.0 and 6.8 μM, respectively.

Anti-HIV-1 Protease Activity of Lanostane Triterpenes from the Vietnamese Mushroom Ganoderma Colossum

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Inhibition of the Dimerization and Active Site of HIV-1 Protease by Secondary Metabolites from the Vietnamese Mushroom Ganoderma Colossum

New lanostane triterpene lactones from the Vietnamese mushroom Ganoderma colossum (FR.) C. F. BAKER.

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Highly modified lanostane triterpenoids from natural fruiting bodies of Ganoderma cf. hochiminhense

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

Isolation of 3,4-Seco-27-norlanostane Triterpenoids from Cultivated Fruiting Bodies of Ganoderma Orbiforme

New Lanostane-Type Triterpenoids from Ganoderma Applanatum.

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Three New Lanostanoids From The Mushroom Ganoderma Tropicum

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

THE TRITERPENOID AND STEROID FROM THE FRUITING BODY OF Ganoderma applanatum (Pers.) Pat. IN VIETNAM

Isolation and Bioactivity Evaluation of Terpenoids from the Medicinal FungusGanoderma Sinense

Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated from Poria cocos

Lanostane-type Triterpenoids from the Fruiting Body of Ganoderma Calidophilum